Flagship Ventures Management
Latest statistics and disclosures from Flagship Pioneering's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MRNA, SANA, FHTX, MCRB, and represent 100.00% of Flagship Pioneering's stock portfolio.
- Flagship Pioneering has $293M in assets under management (AUM), dropping by 9.00%.
- Central Index Key (CIK): 0001400240
Tip: Access up to 7 years of quarterly data
Positions held by Flagship Ventures Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 4 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Moderna (MRNA) | 40.9 | $120M | 4.6M | 25.83 |
|
|
| Sana Biotechnology (SANA) | 30.3 | $89M | 25M | 3.55 |
|
|
| Foghorn Therapeutics (FHTX) | 21.2 | $62M | 13M | 4.89 |
|
|
| Seres Therapeutics (MCRB) | 7.6 | $22M | 1.2M | 19.24 |
|
Past Filings by Flagship Pioneering
SEC 13F filings are viewable for Flagship Pioneering going back to 2016
- Flagship Pioneering 2025 Q3 filed Nov. 14, 2025
- Flagship Pioneering 2025 Q2 filed Aug. 14, 2025
- Flagship Pioneering 2025 Q1 filed May 15, 2025
- Flagship Pioneering 2024 Q4 filed Feb. 14, 2025
- Flagship Pioneering 2024 Q3 filed Nov. 14, 2024
- Flagship Pioneering 2024 Q2 filed Aug. 14, 2024
- Flagship Pioneering 2024 Q1 filed May 15, 2024
- Flagship Pioneering 2023 Q4 filed Feb. 14, 2024
- Flagship Pioneering 2023 Q3 filed Nov. 14, 2023
- Flagship Pioneering 2023 Q2 filed Aug. 14, 2023
- Flagship Pioneering 2023 Q1 filed May 15, 2023
- Flagship Pioneering 2022 Q4 filed Feb. 14, 2023
- Flagship Pioneering 2022 Q3 filed Nov. 14, 2022
- Flagship Pioneering 2022 Q2 filed Aug. 15, 2022
- Flagship Pioneering 2022 Q1 filed May 16, 2022
- Flagship Pioneering 2021 Q4 filed Feb. 14, 2022